Management of Rhythm and Conduction Disorders in Cardiac Amyloidosis: A French Nationwide Delphi Study.

ABSTRACT:

Background

Cardiac amyloidosis (CA) is an increasingly recognized cardiomyopathy with an associated risk of arrhythmias and conduction disorders; however, managing arrhythmias and conductive disorders remains largely undefined.

Objectives

This study aims to gather French expert experience on current practices and treatment strategies for managing arrhythmias and conduction disorders in CA. The main areas of interest included atrial fibrillation (AF) management, anticoagulation therapy, and criteria for implanting cardiac rhythm devices.

Methods

A modified Delphi method was employed, involving a panel of 56 cardiologists and electrophysiologists specializing in CA. The panel evaluated 248 statements over 2 rounds. Consensus was defined as agreement from at least 66.7%

SUBMITTER: Guenancia C 

PROVIDER: S-EPMC11872529 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature